232 related articles for article (PubMed ID: 116210)
1. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice].
Grochowski J; Bilinska M; Stankiewicz D; Arkusiewicz E
Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210
[No Abstract] [Full Text] [Related]
2. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
3. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
[No Abstract] [Full Text] [Related]
4. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
Gerasimova LI; Moroz AF; Radkevich SA; Sveshnikov AI; Mizikin EV
Khirurgiia (Mosk); 1980 Nov; (11):36-41. PubMed ID: 6777578
[No Abstract] [Full Text] [Related]
5. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
[No Abstract] [Full Text] [Related]
6. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
7. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
[No Abstract] [Full Text] [Related]
8. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns.
Jones RJ; Lowbury EJ
Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411
[TBL] [Abstract][Full Text] [Related]
9. Immunological control of pseudomonas infection in burns.
R I Med J; 1972 Mar; 55(3):88. PubMed ID: 4622683
[No Abstract] [Full Text] [Related]
10. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients.
Gonzáles Ayala SE; Daroda M; Villa J; Cecchini E; Vich J
Panminerva Med; 1983; 25(3):203-8. PubMed ID: 6422426
[No Abstract] [Full Text] [Related]
11. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
Moroz AF; Kharitonova AM; Chanturiia TsK
Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
[TBL] [Abstract][Full Text] [Related]
12. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
Lieberman MM; Walker HL; Ayala E; Chapa I
J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
[TBL] [Abstract][Full Text] [Related]
13. Effects of elastase, protease and common antigen (OEP) from Pseudomonas aeruginosa on protection against burns in mice.
Kawaharajo K; Homma JY
Jpn J Exp Med; 1977 Dec; 47(6):495-500. PubMed ID: 416253
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine.
Pranter W; Staerk J; Zellner R; Zwisler O
Prog Immunobiol Stand; 1971; 5():414-8. PubMed ID: 4633968
[No Abstract] [Full Text] [Related]
15. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
[No Abstract] [Full Text] [Related]
16. Pivotal advance: glycyrrhizin restores the impaired production of beta-defensins in tissues surrounding the burn area and improves the resistance of burn mice to Pseudomonas aeruginosa wound infection.
Yoshida T; Yoshida S; Kobayashi M; Herndon DN; Suzuki F
J Leukoc Biol; 2010 Jan; 87(1):35-41. PubMed ID: 19843573
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
[No Abstract] [Full Text] [Related]
18. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
Meitert E; Meitert T; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
[No Abstract] [Full Text] [Related]
19. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
Okada K; Kawaharajo K; Kasai T; Homma JY
Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
[TBL] [Abstract][Full Text] [Related]
20. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]